UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 812

Sortiert nach

Increasing Prevalence of Artemisinin-Resistant HRP2-Negative Malaria in Eritrea

The New England journal of medicine, 2023-09, Vol.389 (13), p.1191-1202

2023

Volltextzugriff (PDF)

Validated assays for human cytochrome P450 activities

Drug metabolism and disposition, 2004-06, Vol.32 (6), p.647

2004

Volltextzugriff (PDF)

Assessment of NR4A Ligands That Directly Bind and Modulate the Orphan Nuclear Receptor Nurr1

Journal of medicinal chemistry, 2020-12, Vol.63 (24), p.15639-15654

2020

Volltextzugriff (PDF)

Antiviral activities of selected antimalarials against dengue virus type 2 and Zika virus

Antiviral research, 2017-01, Vol.137, p.141-150

2017

Volltextzugriff (PDF)

Exploring the modulatory influence on the antimalarial activity of amodiaquine using scaffold hybridisation with ferrocene integration

European journal of medicinal chemistry, 2024-05, Vol.271, p.116429-116429, Article 116429

2024

Volltextzugriff (PDF)

Antimalarial artemisinin-based combination therapies (ACT) and COVID-19 in Africa: In vitro inhibition of SARS-CoV-2 replication by mefloquine-artesunate

International journal of infectious diseases, 2020-10, Vol.99, p.437-440

2020

Volltextzugriff (PDF)

Nuclear receptor Nurr1 agonists enhance its dual functions and improve behavioral deficits in an animal model of Parkinson’s disease

Proceedings of the National Academy of Sciences - PNAS, 2015-07, Vol.112 (28), p.8756-8761

2015

Volltextzugriff (PDF)

Efficacy and safety of artemisinin-based combination therapy and the implications of Pfkelch13 and Pfcoronin molecular markers in treatment failure in Senegal

Scientific reports, 2020-06, Vol.10 (1), p.8907, Article 8907

2020

Volltextzugriff (PDF)

High-Content Screening in hPSC-Neural Progenitors Identifies Drug Candidates that Inhibit Zika Virus Infection in Fetal-like Organoids and Adult Brain

Cell stem cell, 2017-08, Vol.21 (2), p.274-283.e5

2017

Volltextzugriff (PDF)

From malaria to cancer: Computational drug repositioning of amodiaquine using PLIP interaction patterns

Scientific reports, 2017-09, Vol.7 (1), p.11401-13, Article 11401

2017

Volltextzugriff (PDF)

Therapeutic efficacy of artemether-lumefantrine, artesunate-amodiaquine and dihydroartemisinin-piperaquine in the treatment of uncomplicated Plasmodium falciparum malaria in Sub-Saharan Africa: A systematic review and meta-analysis

PloS one, 2022-03, Vol.17 (3), p.e0264339-e0264339

2022

Volltextzugriff (PDF)

Exploring the repositioning of the amodiaquine as potential drug against visceral leishmaniasis: The in vitro effect against Leishmania infantum is associated with multiple mechanisms, involving mitochondria dysfunction, oxidative stress and loss of cell cycle control

Chemico-biological interactions, 2023-02, Vol.371, p.110333, Article 110333

2023

Volltextzugriff (PDF)

Artesunate-amodiaquine and artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in Liberia: in vivo efficacy and frequency of molecular markers

Malaria journal, 2022-04, Vol.21 (1), p.134-134, Article 134

2022

Volltextzugriff (PDF)

Amodiaquine derivatives as inhibitors of severe fever with thrombocytopenia syndrome virus (SFTSV) replication

Antiviral research, 2023-02, Vol.210, p.105479, Article 105479

2023

Volltextzugriff (PDF)

Inhibition of Stearoyl-CoA Desaturase 1 Potentiates Anti-tumor Activity of Amodiaquine in Non-small Cell Lung Cancer

Biological and Pharmaceutical Bulletin, 2022/04/01, Vol.45(4), pp.438-445

2022

Volltextzugriff (PDF)

The antimalarial drug amodiaquine stabilizes p53 through ribosome biogenesis stress, independently of its autophagy-inhibitory activity

Cell death and differentiation, 2020-02, Vol.27 (2), p.773-789

2020

Volltextzugriff (PDF)

Investigation of the interaction between amodiaquine and human serum albumin by fluorescence spectroscopy and molecular modeling

European journal of medicinal chemistry, 2012-08, Vol.54, p.255-263

2012

Volltextzugriff (PDF)

Rapid increase in resistance of Plasmodium falciparum to chloroquine-Fansidar in Uganda and the potential of amodiaquine-Fansidar as a better alternative

Acta tropica, 2005-09, Vol.95 (3), p.172-182

2005

Volltextzugriff (PDF)

Malaria PK/PD and the Role Pharmacometrics Can Play in the Global Health Arena: Malaria Treatment Regimens for Vulnerable Populations

Clinical pharmacology and therapeutics, 2021-10, Vol.110 (4), p.926-940

2021

Volltextzugriff (PDF)

Novel amodiaquine derivatives potently inhibit Ebola virus infection

Antiviral research, 2018-12, Vol.160, p.175-182

2018

Volltextzugriff (PDF)

Role of Pfmdr1 in in vitro Plasmodium falciparum susceptibility to chloroquine, quinine, monodesethylamodiaquine, mefloquine, lumefantrine, and dihydroartemisinin

Antimicrobial agents and chemotherapy, 2014-12, Vol.58 (12), p.7032-7040

2014

Volltextzugriff (PDF)

Amodiaquine, an antimalarial drug, inhibits dengue virus type 2 replication and infectivity

Antiviral research, 2014-06, Vol.106, p.125-134

2014

Volltextzugriff (PDF)

Revisiting the circulation time of Plasmodium falciparum gametocytes: molecular detection methods to estimate the duration of gametocyte carriage and the effect of gametocytocidal drugs

Malaria journal, 2010-05, Vol.9 (1), p.136-136, Article 136

2010

Volltextzugriff (PDF)

The antimalarial drug amodiaquine possesses anti‐ZIKA virus activities

Journal of medical virology, 2018-05, Vol.90 (5), p.796-802

2018

Volltextzugriff (PDF)

1 – 25 von 812

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(720)
Mit Volltextzugriff
(632)

Publikationsform

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(648)
Life Sciences & Biomedicine
(604)
Humans
(545)
Animals
(384)
Amodiaquine - Pharmacology
(357)
Amodiaquine
(344)
Antimalarials - Pharmacology
(315)
Biological And Medical Sciences
(306)
Malaria
(302)
Plasmodium Falciparum - Drug Effects
(300)
Medical Sciences
(293)
Pharmacology & Pharmacy
(288)
Pharmacology. Drug Treatments
(264)
Plasmodium Falciparum
(259)
Male
(258)
Female
(248)
Amodiaquine - Therapeutic Use
(242)
Drug Resistance
(222)
Antimalarials - Therapeutic Use
(216)
Chloroquine - Pharmacology
(216)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Increasing Prevalence of Artemisinin-Resistant HRP2-Negative Malaria in Eritrea

Validated assays for human cytochrome P450 activities

Assessment of NR4A Ligands That Directly Bind and Modulate the Orphan Nuclear Receptor Nurr1

Antiviral activities of selected antimalarials against dengue virus type 2 and Zika virus

Exploring the modulatory influence on the antimalarial activity of amodiaquine using scaffold hybridisation with ferrocene integration

Antimalarial artemisinin-based combination therapies (ACT) and COVID-19 in Africa: In vitro inhibition of SARS-CoV-2 replication by mefloquine-artesunate

Nuclear receptor Nurr1 agonists enhance its dual functions and improve behavioral deficits in an animal model of Parkinson’s disease

Efficacy and safety of artemisinin-based combination therapy and the implications of Pfkelch13 and Pfcoronin molecular markers in treatment failure in Senegal

High-Content Screening in hPSC-Neural Progenitors Identifies Drug Candidates that Inhibit Zika Virus Infection in Fetal-like Organoids and Adult Brain

From malaria to cancer: Computational drug repositioning of amodiaquine using PLIP interaction patterns

Therapeutic efficacy of artemether-lumefantrine, artesunate-amodiaquine and dihydroartemisinin-piperaquine in the treatment of uncomplicated Plasmodium falciparum malaria in Sub-Saharan Africa: A systematic review and meta-analysis

Exploring the repositioning of the amodiaquine as potential drug against visceral leishmaniasis: The in vitro effect against Leishmania infantum is associated with multiple mechanisms, involving mitochondria dysfunction, oxidative stress and loss of cell cycle control

Artesunate-amodiaquine and artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in Liberia: in vivo efficacy and frequency of molecular markers

Amodiaquine derivatives as inhibitors of severe fever with thrombocytopenia syndrome virus (SFTSV) replication

Inhibition of Stearoyl-CoA Desaturase 1 Potentiates Anti-tumor Activity of Amodiaquine in Non-small Cell Lung Cancer

The antimalarial drug amodiaquine stabilizes p53 through ribosome biogenesis stress, independently of its autophagy-inhibitory activity

The duration of chemoprophylaxis against malaria after treatment with artesunate-amodiaquine and artemether-lumefantrine and the effects of pfmdr1 86Y and pfcrt 76T: a meta-analysis of individual patient data

Investigation of the interaction between amodiaquine and human serum albumin by fluorescence spectroscopy and molecular modeling

Rapid increase in resistance of Plasmodium falciparum to chloroquine-Fansidar in Uganda and the potential of amodiaquine-Fansidar as a better alternative

Malaria PK/PD and the Role Pharmacometrics Can Play in the Global Health Arena: Malaria Treatment Regimens for Vulnerable Populations

Novel amodiaquine derivatives potently inhibit Ebola virus infection

Role of Pfmdr1 in in vitro Plasmodium falciparum susceptibility to chloroquine, quinine, monodesethylamodiaquine, mefloquine, lumefantrine, and dihydroartemisinin

Amodiaquine, an antimalarial drug, inhibits dengue virus type 2 replication and infectivity

Revisiting the circulation time of Plasmodium falciparum gametocytes: molecular detection methods to estimate the duration of gametocyte carriage and the effect of gametocytocidal drugs

The antimalarial drug amodiaquine possesses anti‐ZIKA virus activities

Suchergebnisse filtern